Regenerex Pharma (RGPX) Change in Account Payables (2011 - 2025)

Regenerex Pharma (RGPX) has 7 years of Change in Account Payables data on file, last reported at $47481.0 in Q3 2025.

• Change in Account Payables for Q3 2025 came in at $47481.0, up 599.69% year-over-year; the trailing twelve-month figure through Sep 2025 was $138905.0 (up 1.59% YoY), and the FY2025 annual result was $187915.0, up 17.71% from the prior year.
• Change in Account Payables improved to $47481.0 in Q3 2025 per RGPX's latest filing, from -$26405.0 in the prior quarter.
• Over five years, Change in Account Payables peaked at $93792.0 in Q2 2023 and troughed at -$26405.0 in Q2 2025.
• A 3-year average of $36863.2 and a median of $49351.0 in 2024 frame the typical range for Change in Account Payables.
• The sharpest annual moves came in 2024 and 2025: Change in Account Payables surged 949.31% in 2024, then sank 141.71% in 2025.
• A 3-year view of Change in Account Payables shows it stood at $9097.0 in 2023, then surged by 463.05% to $51221.0 in 2024, then dropped by 7.3% to $47481.0 in 2025.
• Business Quant data shows RGPX's Change in Account Payables at $47481.0 in Q3 2025, -$26405.0 in Q2 2025, and $66608.0 in Q1 2025.